Healthcare M&A in 2025 was shaped by disciplined capital deployment, increased regulatory scrutiny, and heightened focus on reimbursement and operating risk. Against this backdrop, our Healthcare M&A, Joint Ventures, and Other Transactions team advised buyers and sellers across the care continuum on more than 125 transactions last year.
Our 2025 Healthcare M&A Year in Review highlights what’s driving deal activity—from how transactions were structured to the issues most likely to influence timing, risk, and execution. Explore the report for practical, deal-driven insights drawn from sponsor-backed and strategic healthcare transactions nationwide.
Download Infosheet